pyridazinamine derivatives (Johnson & Johnson)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepyridazinamine derivatives (Johnson & Johnson)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsPsoriasisEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsPsoriasisEye DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A